803P Patient-reported outcomes in patients with resected, stage III BRAF V600+ melanoma treated with adjuvant dabrafenib + trametinib: COMBI-APlus studyJean‐Jacques Grob, Victoria Atkinson, Alexander M. Menzies et al.|Annals of Oncology|2022Cited by 2